Quarterly report pursuant to Section 13 or 15(d)

Revenue Information

v3.19.2
Revenue Information
6 Months Ended
Jun. 30, 2019
Segment Reporting [Abstract]  
Revenue Information

Note 10 – Revenue Information

 

Revenue by product lines was as follows:

 

    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
Product Line   2019     2018     2019     2018  
MicroParticle Catalyzed Biosensor (“MPC”)   $ 65,344     $ 106,680     $ 88,664     $ 125,630  
Particle ImmunoFiltration Assay (“PIFA”)     304,658       356,082       880,973       616,066  
Rapid Enzymatic Assay (“REA”)     85,000       45,100       85,000       55,000  
Other     9,511       18,739       21,997       32,380  
Total Revenue   $ 464,513     $ 526,601     $ 1,076,634     $ 829,076  

 

The total revenue by geographic area determined based on the location of the customers was as follows:

 

    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
Geographic Region   2019     2018     2019     2018  
United States   $ 447,013     $ 462,383     $ 1,059,134     $ 757,116  
Rest of World     17,500       64,218       17,500       71,960  
Total Revenue   $ 464,513     $ 526,601     $ 1,076,634     $ 829,076  

 

The Company had long-lived assets totaling $13,097 and $14,294 located in the People’s Republic of China and $278,791 and $312,573 located in the United States as of June 30, 2019 and December 31, 2018, respectively.